| Cigna EviCore | MOL.CU.115.A: Genetic Testing to Predict Disease Risk | 2026-01-01 |
| Cigna EviCore | MOL.CU.116.A: Genetic Testing by Multigene Panels | 2026-01-01 |
| Cigna EviCore | MOL.CU.117.A: Experimental, Investigational, or Unproven Laboratory Testing | 2026-01-01 |
| Cigna EviCore | MOL.CU.118.A: Pharmacogenomic Testing for Drug Toxicity and Response | 2026-01-01 |
| Cigna EviCore | MOL.CU.119.A: Preimplantation Genetic Screening and Diagnosis | 2026-01-01 |
| Cigna EviCore | MOL.CU.246.A: Hereditary (Germline) Testing After Tumor (Somatic) Testing | 2026-01-01 |
| Cigna EviCore | MOL.CU.256.A: Confirmatory Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.CU.291.A: Genetic Testing for Known Familial Mutations | 2026-01-01 |
| Cigna EviCore | MOL.CU.292.A: Genetic Testing for Variants of Uncertain Clinical Significance | 2026-01-01 |
| Cigna EviCore | MOL.CU.333.B: Medically Necessary Laboratory Testing | 2026-01-01 |